Clinical Trial Update: Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia [Phase 1]

View source ↗

Summary

Phase I study evaluating the safety, tolerability, and pharmacokinetics of FK463 in immunocompromised children with fever and neutropenia; the trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycoses
• Neutropenia

Drugs mentioned

• FK463 (FK463)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fever, Mycoses | Phase 1 | Status: COMPLETED